Results for tag: "Androgen Insensitivity Syndrome Drug"

Androgen Insensitivity Syndrome (AIS) is a rare genetic disorder that affects the development of the reproductive system in individuals with XY chromosomes. It is caused by a mutation in the androgen receptor gene, which results in the body's inability to respond to androgens, such as testosterone. As a result, individuals with AIS may have a variety of physical characteristics, including ambiguous genitalia, infertility, and a lack of secondary sex characteristics. Treatment for AIS typically involves hormone replacement therapy, which can help to reduce the symptoms of the disorder. The Androgen Insensitivity Syndrome Drug market is a specialized segment of the Endocrine and Metabolic Disorders Drugs market. It is focused on providing treatments for individuals with AIS, such as hormone replacement therapy. These drugs are typically prescribed by endocrinologists and other healthcare professionals. Companies in the Androgen Insensitivity Syndrome Drug market include Pfizer, Merck, Novartis, and Sanofi. Show Less Read more